|
|
 |
|
Viewing report
|
|
|
|
Healthcare Review: Cancer - October 2002
Datamonitor, Feb 2002
The Cancer Review brings you the latest news, expert analysis and research in the oncology industry. It covers all the major current business issues and events, including R&D, licensing deals, alliances and joint ventures, and regulatory decisions.Strategic insight into the future shape of cancer companies and marketsThe most significant cancer industry news compiled into one monthly updateExpert analysis into the implications of the month's important cancer industry eventsInsight into the future shape of the market for players at all levelsAll the month's cancer stories in headline and summary formOut of the dozens of topics covered in this month's review, the most important include:* Novartis's Gleevec was granted a priority review by the FDA for possible use as a first-line treatment for newly diagnosed patients with Philadelphia-chromosome positive chronic myeloid leukemia in the chronic phase, the earliest stage of the disease.* A US District Court jury found unanimously in favor of Genentech following the claims of Chiron's that Genentech had infringed a patent with its metastatic breast cancer drug, Herceptin.Not only keeps you updated about industry events - it also gives you opinion and insightDraws upon Datamonitor analysts' extensive experience to bring you our perspective on the impact of the latest eventsProvides you with your own news archive to track company and industry progress, giving you an extensive reference to relevant events and issues
Customers who bought this item also bought
Bisphosphonates Update - The Treatment and Prevention of Bone Metastases in Breast and Prostate Cancer
Drugs of Tomorrow: Cancer Overview
Drugs of Tomorrow 2001: Cancer Overview
Q2 2008 Earnings Call - BR Malls Participaçoes SA, - Earnings Transcript
Q1 2008 Earnings Call - BR Malls Participaçoes SA, - Earnings Transcript
Q1 2009 Earnings Call - BR Malls Participaçoes SA, - Earnings Transcript
Br Malls Participacoes Sa
Br. Holdings Corporation
Breast Cancer Insight - Defining Drug Decisions - How Can Companies Influence the Treatment of Breast Cancer?
Healthcare Review: CNS - September 2002
The 2009 Import and Export Market for Butadiene Rubber (BR) in France
The 2009 Import and Export Market for Butadiene Rubber (BR) in Germany
|
|
|
|
